Consultant Cardiology Assessment
Blood Pressure Log - Summary
| Date & Time | SYS (mmHg) | DIA (mmHg) | Pulse (bpm) |
|---|
| July 8, 2026 - 9:40 PM | 167 | 126 | 87 |
| July 9, 2026 - 5:43 AM | 136 | 111 | 88 |
| July 9, 2026 - 1:33 PM | 145 | 114 | 96 |
| July 9, 2026 - 9:15 PM | 157 | 112 | 89 |
Pattern: Consistently elevated BP across morning, afternoon, and evening. No single-reading artifact - this is a reproducible pattern over 24+ hours. Diastolic is persistently in the 111-126 mmHg range. This is Stage 2 Hypertension / hypertensive urgency confirmed across multiple readings on two consecutive days.
ECG Interpretation
Settings: 25 mm/s, 10 mm/mV (standard calibration)
Findings:
| Parameter | Finding |
|---|
| Rate | ~60-65 bpm |
| Rhythm | Normal Sinus Rhythm |
| Axis | Left Axis Deviation (LAD), approximately -45° to -60° |
| P waves | Normal morphology, PR ~160 ms |
| QRS duration | 80-90 ms (narrow - no BBB) |
| QRS morphology | qR in I and aVL; rS in II, III, aVF |
| R-wave progression | Poor R-wave progression V1-V3 |
| ST segments | Isoelectric - no acute ST changes |
| T waves | Inversion in V1-V2; upright and normal in lateral leads |
| LVH voltage criteria | NOT met (Sokolow-Lyon ~22 mm; Cornell ~18 mm - both below thresholds) |
Primary ECG Diagnosis:
Left Anterior Fascicular Block (LAFB)
- Marked LAD (more negative than -30°, here ~-45° to -60°)
- qR pattern in I and aVL
- rS pattern in II, III, and aVF
- Normal QRS duration (excludes complete LBBB)
- No right bundle branch block features
Secondary Findings:
- Poor R-wave progression (PRWP) in V1-V3 - could reflect anterior wall changes (old anteroseptal MI? anteroseptal fibrosis? LAFB effect itself)
- T-wave inversions V1-V2 - could be right ventricular strain, anterior ischemia, or persistent juvenile pattern; needs clinical correlation
- No LVH by voltage - however, note that LAFB can mask LVH voltage criteria (a recognized limitation of ECG screening for LVH in LAFB)
Clinical Interpretation & Management Plan
What This Picture Tells Me:
This patient has untreated Stage 2 Hypertension with a significant diastolic component (mean diastolic ~116 mmHg over 24 hours). The ECG shows LAFB - a conduction abnormality that in the context of hypertension raises important questions:
LAFB + Hypertension + PRWP forms a concerning triad. LAFB is not always benign - in hypertensive patients it can be an early marker of:
- Hypertensive cardiac remodeling (even without meeting formal LVH voltage criteria)
- Subclinical coronary artery disease (especially relevant given the PRWP in V1-V3)
- Early cardiomyopathy
The persistently elevated diastolic BP (111-126 mmHg) at rest, across different times of day, without any antihypertensive therapy, represents hypertensive urgency (elevated BP >180/120 or in this case consistent severe diastolic elevation without evidence of acute end-organ damage on this ECG alone).
Recommended Investigations
Urgent (within 24-48 hours):
- Renal function panel - serum creatinine, urea, eGFR (rule out hypertensive nephropathy / renovascular cause)
- Urine analysis + urine protein:creatinine ratio - look for proteinuria (renal end-organ damage)
- Fasting blood glucose and HbA1c - metabolic risk assessment
- Serum electrolytes (K+, Na+) - baseline before starting medications
- Lipid profile - cardiovascular risk stratification
- Fundoscopy (dilated) - grade hypertensive retinopathy
- Echocardiogram (2D Echo with Doppler) - this is the most important cardiac investigation:
- Will detect LVH that ECG voltage criteria miss (especially in the presence of LAFB)
- Assess diastolic dysfunction (Grade I-III)
- Evaluate wall motion abnormalities (especially anterior wall, given PRWP on ECG)
- Measure LVEF
To Exclude Secondary Hypertension (given severity with no prior treatment):
- TSH - thyroid disease
- Serum cortisol / 24-hour urine catecholamines if clinically suspected (Cushing's / pheochromocytoma)
- Renal artery Doppler - if renal function is impaired or there is a clinical suspicion of renovascular hypertension
- Aldosterone:Renin ratio - if hypokalemia is found (primary hyperaldosteronism)
Cardiac Workup for PRWP + T-wave inversions V1-V2:
- Troponin I or T - to exclude acute/subacute coronary event
- Previous ECGs for comparison, if available
Treatment Recommendation
Immediate:
Since this is hypertensive urgency (not emergency - no evidence of acute end-organ damage on ECG, and presumably no acute neurological symptoms), the goal is gradual reduction of BP over 24-48 hours, NOT rapid lowering.
Initiate antihypertensive therapy today:
Given the high diastolic component and likely hypertensive heart disease, a combination approach is appropriate for Stage 2 hypertension at presentation:
First-line Drug Choice:
| Drug | Dose | Rationale |
|---|
| Amlodipine (CCB) | 5 mg once daily | First-line for hypertension, cardioprotective, well-tolerated |
| Telmisartan (ARB) | 40 mg once daily | Excellent for diastolic hypertension, renoprotective, preferred over ACE-inhibitor in South Asian patients (less cough) |
- Start both simultaneously given the severity
- Target: SBP <130 mmHg, DBP <80 mmHg (ACC/AHA 2017 guidelines)
- Telmisartan 40-80 mg also provides 24-hour coverage - particularly good for early-morning surge (note the 5:43 AM reading of 136/111)
If diastolic remains above 110 mmHg at follow-up in 2 weeks, add Indapamide 1.5 mg SR (thiazide-like diuretic) as third agent.
Lifestyle Modifications (mandatory, not optional):
- Dietary sodium restriction: <2 g/day (DASH diet)
- Weight loss if overweight
- Alcohol restriction
- Regular aerobic exercise 30 min/day, 5 days/week
- Smoking cessation if applicable
- Stress management
Regarding the LAFB:
LAFB itself requires no specific treatment. However:
- It must be documented as a baseline finding
- If a future ECG shows new RBBB + LAFB (bifascicular block), the patient would need EP evaluation for potential pacemaker risk
- With good BP control, progression of fascicular disease may slow
- Echocardiogram is essential to determine if structural heart disease underlies the LAFB
Summary Statement
This is a patient with newly identified, untreated, severe Stage 2 hypertension (multiple readings over 136-167/111-126 mmHg) with an ECG showing LAFB, poor R-wave progression, and anterior T-wave changes. The most likely explanation is hypertensive cardiac remodeling, but anterior wall disease (old infarct or ischemia) cannot be excluded. I would start dual antihypertensive therapy today, obtain urgent labs and an echocardiogram, and arrange a cardiology follow-up in 2 weeks with all results. If troponin comes back elevated or the echo shows regional wall motion abnormality, coronary angiography would be the next step.
Important note: This analysis is based on the images provided. A complete history (age, sex, symptoms, family history, duration of hypertension, associated conditions) and physical examination are essential before finalizing any management plan. This represents educational clinical reasoning and should be used in conjunction with direct patient evaluation by a qualified physician.